Inducible Human Endothelin-1 Overexpression in Endothelium Raises Blood Pressure via Endothelin Type A Receptors

Hypertension

Volumn 66, Issue 2, 2015, Pages 347-355

  Rautureau, Yohann ^a   Coelho, Suellen C ^a   Fraulob Aquino, Julio C ^a   Huo, Ku Geng ^a   Rehman, Asia ^a   Offermanns, Stefan ^c   Paradis, Pierre ^a   Schiffrin, Ernesto L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

Author keywords

Blood pressure; Endothelin receptors type A; Endothelin 1; Endothelium; Mice, transgenic

Indexed keywords

ATRASENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; TAMOXIFEN; EDNRB PROTEIN, HUMAN; ENDOTHELIN RECEPTOR; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; GENE OVEREXPRESSION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PERFUSION; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; HYPERTENSION; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; TAMOXIFEN; UP-REGULATION;

EID: 84937554493     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05168     Document Type: Article

References (29)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415. doi: 10.1038/332411a0
2. Miyauchi T, Masaki T., Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 1999;61:391-415. doi: 10.1146/annurev.physiol.61.1.391
3. Dhaun N, Goddard J, Kohan DE, Pollock DM, Schiffrin EL, Webb DJ., Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension 2008;52:452-459. doi: 10.1161/HYPERTENSIONAHA.108.117366
4. Rautureau Y, Schiffrin EL., Endothelin in hypertension: An update. Curr Opin Nephrol Hypertens 2012;21:128-136. doi: 10.1097/MNH.0b013e32834f0092
5. Saito Y, Nakao K, Mukoyama M, Imura H., Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990;322:205.
6. Schiffrin EL, Deng LY, Sventek P, Day R., Enhanced expression of endothelin-1 gene in resistance arteries in severe human essential hypertension. J Hypertens 1997;15:57-63.
7. Larivière R, Thibault G, Schiffrin EL., Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993;21:294-300.
8. Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM., Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 1995;25(4 Pt 2)769-773.
9. Blezer EL, Nicolay K, Goldschmeding R, Jansen GH, Koomans HA, Rabelink TJ, Joles JA., Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats. Hypertension 1999;33:137-144.
10. Ikeda T, Ohta H, Okada M, Kawai N, Nakao R, Siegl PK, Kobayashi T, Maeda S, Miyauchi T, Nishikibe M., Pathophysiological roles of endothelin-1 in Dahl salt-sensitive hypertension. Hypertension 1999;34:514-519.
11. Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao WH, Kamada N., Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703-710. doi: 10.1038/368703a0
12. Kisanuki YY, Emoto N, Ohuchi T, Widyantoro B, Yagi K, Nakayama K, Kedzierski RM, Hammer RE, Yanagisawa H, Williams SC, Richardson JA, Suzuki T, Yanagisawa M., Low blood pressure in endothelial cell-specific endothelin 1 knockout mice. Hypertension 2010;56:121-128. doi: 10.1161/HYPERTENSIONAHA.109.138701
13. Hocher B, Thöne-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F., Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 1997;99:1380-1389. doi: 10.1172/JCI119297
14. Shindo T, Kurihara H, Maemura K, Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1. J Mol Med (Berl) 2002;80:105-116. doi: 10.1007/s00109-001-0284-4
15. Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, Schiffrin EL., Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 2004;110:2233-2240. doi: 10.1161/01.CIR.0000144462.08345.B9
16. Amiri F, Paradis P, Reudelhuber TL, Schiffrin EL., Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells. J Hypertens 2008;26:1102-1109. doi: 10.1097/HJH.0b013e3282fc2184
17. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN., Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A 1997;94:3058-3063.
18. Bakris GL, Lindholm LH, Black HR, Krum H, Linas S, Linseman JV, Arterburn S, Sager P, Weber M., Divergent results using clinic and ambulatory blood pressures: Report of a darusentan-resistant hypertension trial. Hypertension 2010;56:824-830. doi: 10.1161/HYPERTENSIONAHA.110.156976
19. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL., T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 2011;57:469-476. doi: 10.1161/HYPERTENSIONAHA.110.162941
20. Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M., Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci U S A 2004;101:6975-6980. doi: 10.1073/pnas.0401833101
21. Korhonen H, Fisslthaler B, Moers A, Wirth A, Habermehl D, Wieland T, Schütz G, Wettschureck N, Fleming I, Offermanns S., Anaphylactic shock depends on endothelial Gq/G11. J Exp Med 2009;206:411-420. doi: 10.1084/jem.20082150
22. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D., Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 1999;27:4324-4327.
23. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L., A global double-fluorescent Cre reporter mouse. Genesis 2007;45:593-605. doi: 10.1002/dvg.20335
24. Guyton AC., Renal function curve- A key to understanding the pathogenesis of hypertension. Hypertension 1987;10:1-6.
25. Kohan DE, Barton M., Endothelin and endothelin antagonists in chronic kidney disease. Kidney Int 2014;86:896-904. doi: 10.1038/ki.2014.143
26. Kohan DE, Rossi NF, Inscho EW, Pollock DM., Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 2011;91:1-77. doi: 10.1152/physrev.00060.2009
27. Glenn ST, Jones CA, Gross KW, Pan L., Control of renin [corrected] gene expression. Pflugers Arch 2013;465:13-21. doi: 10.1007/s00424-012-1110-2
28. Vignon-Zellweger N, Relle K, Rahnenführer J, Schwab K, Hocher B, Theuring F., Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female mice. Life Sci 2014;118:219-225. doi: 10.1016/j.lfs.2013.12.003
29. Lozano R, Naghavi M, Foreman K, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128. doi: 10.1016/S0140-6736(12)61728-0